Skip to main content
Year archive

Innate Pharma — 2021 filings

All 123 regulatory filings released by Innate Pharma (IPH) in 2021, sourced directly from the official regulator.

123 Filings
2021 Period
2021 filings (123)
Filing Released Lang
INNATE PHARMA S.A. 6-K
Foreign Filer Report
2021-12-16 English
Inside Information / Other news releases
Regulatory Filings
2021-12-16 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2021-12-16 French
INNATE PHARMA S.A. FORM 6-K
Foreign Filer Report
2021-12-09 English
Informations privilégiées / Autres communiqués
Earnings Release FY 2021
2021-12-09 French
Inside Information / Other news releases
Regulatory Filings
2021-12-09 English
INNATE PHARMA S.A. 6-K
Foreign Filer Report
2021-12-02 English
Informations privilégiées / Autres communiqués
Report Publication Announcement
2021-12-02 French
Inside Information / Other news releases
Regulatory Filings
2021-12-02 English
INNATE PHARMA S.A. 6-K
Foreign Filer Report
2021-11-24 English
Inside Information / Other news releases
Report Publication Announcement
2021-11-24 English
Informations privilégiées / Autres communiqués
Investor Presentation
2021-11-24 French
INNATE PHARMA S.A. FORM 6-K
Foreign Filer Report
2021-11-16 English
Quarterly financial reporting / Third quarter financial report
Earnings Release 9M 2021
2021-11-16 English
Information financière trimestrielle / Information financière du troisième trimestre
Earnings Release 9M 2021
2021-11-16 French
INNATE PHARMA S.A. 6-K
Foreign Filer Report
2021-11-12 English
Informations privilégiées / Autres communiqués
Investor Presentation
2021-11-12 French
Inside Information / Other news releases
Earnings Release FY 2021
2021-11-12 English
INNATE PHARMA S.A. 6-K
Foreign Filer Report
2021-11-09 English
Inside Information / Other news releases
Call Transcript
2021-11-09 English
Informations privilégiées / Autres communiqués
Report Publication Announcement
2021-11-09 French
INNATE PHARMA S.A. 6-K
Foreign Filer Report
2021-10-26 English
Inside Information / Other news releases
Report Publication Announcement
2021-10-26 English
Informations privilégiées / Autres communiqués
Report Publication Announcement
2021-10-26 French
INNATE PHARMA S.A. 6-K
Foreign Filer Report
2021-10-15 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements
2021-10-15 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements
2021-10-15 English
FORM 6-K
Foreign Filer Report
2021-09-23 English
Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er septembre 2021
Share Issue/Capital Change
2021-09-23 French
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
Share Issue/Capital Change
2021-09-23 English
FORM 6-K
Foreign Filer Report
2021-09-17 English
Présentation de Données Issues de l'Essai COAST Comprenant Monalizumab au Congrès de l'ESMO 2021
Regulatory Filings
2021-09-17 French
Monalizumab Data From COAST Trial Presented at ESMO Congress 2021
Regulatory Filings
2021-09-17 English
6-K
Foreign Filer Report
2021-09-15 English
Rapport Financier Semestriel 30 juin 2021
Interim / Quarterly Report H1 2021
2021-09-15 French
Innate Pharma reports first half 2021 financial results and business update
Earnings Release H1 2021
2021-09-15 English
FORM 6-K
Foreign Filer Report
2021-09-07 English
Innate Pharma Organise une Conférence Téléphonique et un Webcast pour ses Résultats Financiers au Premier Semestre 2021
Regulatory Filings
2021-09-07 French
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
Call Transcript
2021-09-07 English
FORM 6-K
Foreign Filer Report
2021-09-02 English
Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress
Investor Presentation
2021-09-02 English
Des données sur monalizumab et ANKET™ seront présentées au congrès virtuel de l’ESMO 2021
Regulatory Filings
2021-09-02 French
FORM 6-K
Foreign Filer Report
2021-08-30 English
FORM 6-K
Foreign Filer Report
2021-08-11 English
Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Aout 2021
Share Issue/Capital Change
2021-08-11 French
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021
Share Issue/Capital Change
2021-08-11 English
S-8
Registration Form
2021-07-12 English
FORM 6-K
Foreign Filer Report
2021-07-12 English
Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Juillet 2021
Share Issue/Capital Change
2021-07-12 French
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021
Share Issue/Capital Change
2021-07-12 English
FORM 6-K
Foreign Filer Report
2021-07-06 English
RESULTATS DE L’ESSAI DE PHASE 2 FORCE, EVALUANT AVDORALIMAB CHEZ LES PATIENTS ATTEINTS D’UNE PNEUMONIE SEVERE DUE AU COVID-19
Earnings Release Q2 2021
2021-07-06 French
Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe Pneumonia
Earnings Release Q3 2021
2021-07-06 English
FORM 6-K
Foreign Filer Report
2021-06-22 English
Innate Pharma présente des données préliminaires de l'essai TELLOMAK montrant une réponse clinique avec lacutamab dans le mycosis fungoides
Earnings Release FY 2021
2021-06-22 French
Innate Pharma presents preliminary data from TELLOMAK trial showing clinical response for lacutamab in mycosis fungoides
Earnings Release FY 2021
2021-06-22 English
FORM 6-K
Foreign Filer Report
2021-06-16 English
Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
Regulatory Filings
2021-06-16 English
Innate Pharma Présentera les Progres de sa Strategie Lors d'un Événement Virtuel a Destination des Investisseurs
Report Publication Announcement
2021-06-16 French
FORM 6-K
Foreign Filer Report
2021-06-14 English
Nouveau Nombre D’Actions et de Droits de Vote d’Innate Pharma au 1er Juin 2021
Share Issue/Capital Change
2021-06-14 French
Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021
Regulatory Filings
2021-06-14 English
FORM 6-K
Foreign Filer Report
2021-06-10 English
Innate Pharma Presentera des Données Issues de sa Plateforme de NK Cell Engagers de Nouvelle Generation au Congrés Annuel de la FOCIS 2021
Regulatory Filings
2021-06-10 French
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
Investor Presentation
2021-06-10 English
FORM 6-K
Foreign Filer Report
2021-06-09 English
New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
Report Publication Announcement
2021-06-09 English
De Nouvelles Données pour Lacutamab Issues de l'Essai TELLOMAK Seront Partagées Lors d'Une Présentation Orale au 16ème Congrès International du Lymphome Malin
Earnings Release FY 2021
2021-06-09 French
FORM 6-K
Foreign Filer Report
2021-05-28 English
Résultats de l’Assemblée Générale d'Innate Pharma
Declaration of Voting Results & Voting Rights Announcements
2021-05-28 French
Outcome of Innate Pharma’s Annual General Meeting
AGM Information
2021-05-28 English
FORM 6-K
Foreign Filer Report
2021-05-25 English
Nouveau Nombre D'Actions et de Droits de Vote d'Innate Pharma au 1er Mai 2021
Share Issue/Capital Change
2021-05-25 French
Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021
Regulatory Filings
2021-05-25 English
FORM 6-K
Foreign Filer Report
2021-05-12 English
Innate Pharma : Assemblée Générale 2021 a Distance
AGM Information
2021-05-12 French
Innate Pharma Virtual 2021 Annual General Meeting
AGM Information
2021-05-12 English
FORM 6-K
Foreign Filer Report
2021-05-11 English
Information Financiere du Premier Trimestre 2021
Earnings Release Q1 2021
2021-05-11 French
Innate Pharma First Quarter 2021 Report
Earnings Release Q1 2021
2021-05-11 English
FORM 6-K
Foreign Filer Report
2021-05-04 English
Innate Pharma Organise une Conférence Téléphonique et un Webcast pour son Information Financière du Premier Trimestre 2021
Report Publication Announcement
2021-05-04 French
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
Report Publication Announcement
2021-05-04 English
FORM 6-K
Foreign Filer Report
2021-04-28 English
Innate Pharma Publie son Document d'Enregistrement Universel 2020 et son Rapport Annuel 2020 sur « Form 20-F »
Report Publication Announcement
2021-04-28 French
Innate Pharma Files its 2020 Universal Registration Document (Document d'Enregistrement Universel) and 2020 Annual Report on Form 20-F
Report Publication Announcement
2021-04-28 English
Document d'enregistrement universel 2020
Annual Report (ESEF) FY 2020
2021-04-27 French
20-F
Annual Report FY 2020
2021-04-27 English
FORM 6-K
Foreign Filer Report
2021-04-21 English
FORM 6-K
Foreign Filer Report
2021-04-21 English
Innate Pharma Annonce la Tenue de son Assemblée Générale 28 Mai 2021
AGM Information
2021-04-21 French
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
AGM Information
2021-04-21 English
FORM 6-K
Foreign Filer Report
2021-04-19 English
NOUVEAU NOMBRE D’ACTIONS ET DE DROITS DE VOTE D’INNATE PHARMA AU 1ER AVRIL 2021
Share Issue/Capital Change
2021-04-19 French
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021
Share Issue/Capital Change
2021-04-19 English
FORM 6-K
Foreign Filer Report
2021-03-18 English
Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille pour l'année 2020
Earnings Release FY 2020
2021-03-18 French
Innate Pharma reports Full Year 2020 financial results and business update
Earnings Release FY 2020
2021-03-18 English
FORM 6-K
Foreign Filer Report
2021-03-16 English
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
Earnings Release FY 2020
2021-03-16 English
Innate Pharma organise une conférence téléphonique et un webcast pour ses résultats financiers 2020
Report Publication Announcement
2021-03-16 French
FORM 6-K
Foreign Filer Report
2021-02-24 English
Number of shares and voting rights of Innate Pharma as of February 1, 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-24 English
Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er février 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-24 French
FORM 6-K
Foreign Filer Report
2021-02-17 English
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference
Investor Presentation
2021-02-17 English
Innate Pharma participera à la 10ème conférence annuelle SVB Leerink Global Healthcare Conference
Regulatory Filings
2021-02-17 French
SC 13D
Major Shareholding Notification
2021-02-12 English
FORM 6-K
Foreign Filer Report
2021-02-09 English
Innate Pharma advances lacutamab clinical development program
Regulatory Filings
2021-02-09 English
FORM 6-K
Foreign Filer Report
2021-02-04 English
Innate Pharma organise une conférence avec des experts sur le rôle potentiel de lacutamab dans les lymphomes à cellules T
Regulatory Filings
2021-02-03 French
Innate Pharma to host key opinion leader discussion on the potential role of lacutamab across T-cell lymphomas
Investor Presentation
2021-02-03 English
Regulatory Filings 2021
Regulatory Filings
2021-01-29 English
Regulatory Filings 2021
Regulatory Filings
2021-01-27 English
Regulatory Filings 2021
Regulatory Filings
2021-01-19 English
F-3
Regulatory Filings
2021-01-13 English
FORM 6-K
Foreign Filer Report
2021-01-05 English
Un premier anticorps multispécifique engageant les cellules NK d'Innate sélectionné par Sanofi comme candidat-médicament
Regulatory Filings
2021-01-05 French
Innate's first NK cell engager selected by Sanofi as drug candidate for development
Regulatory Filings
2021-01-05 English
FORM 6-K
Foreign Filer Report
2021-01-04 English
Prochains rendez-vous investisseurs d'Innate Pharma
Report Publication Announcement
2021-01-04 French
Innate Pharma to participate in upcoming investor conferences
Report Publication Announcement
2021-01-04 English